Biomarker for cancer detection and treatment evaluation - the potential of MR metabolomics
- Prosjektnummer
- 46048200
- Ansvarlig person
- Tone Frost Bathen
- Institusjon
- NTNU, ISB
- Prosjektkategori
- Forskerstipend 2011
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.
Hum Pathol 2013 Sep;44(9):1859-66. Epub 2013 mai 6
PMID: 23656974
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
PLoS One 2013;8(4):e62375. Epub 2013 apr 23
PMID: 23626811
Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery.
PLoS One 2013;8(4):e61578. Epub 2013 apr 17
PMID: 23613877
Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study.
PLoS One 2012;7(7):e42330. Epub 2012 jul 30
PMID: 22860113
Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.
Proc Natl Acad Sci U S A 2012 Sep;109(38):E2506; author reply E2507. Epub 2012 jul 31
PMID: 22851771
Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
NMR Biomed 2012 Nov;25(11):1271-9. Epub 2012 mar 8
PMID: 22407957
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
BMC Cancer 2012;12():39. Epub 2012 jan 25
PMID: 22277092
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
J Magn Reson Imaging 2012 May;35(5):1098-107. Epub 2011 des 14
PMID: 22170753
Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
J Magn Reson Imaging 2011 Nov;34(5):1099-109. Epub 2011 aug 23
PMID: 22002757
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
MAGMA 2011 Dec;24(6):347-57. Epub 2011 sep 10
PMID: 21909791
Monitoring neoadjuvant chemotherapy in breast cancer patients: Improved MR assessment at 3 T?
J Magn Reson Imaging 2011 Jul. Epub 2011 jul 14
PMID: 21761463
HR MAS MR spectroscopy in metabolic characterization of cancer.
Curr Top Med Chem 2011;11(1):2-26.
PMID: 20809888
- Tone Frost Bathen Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU